Edgewise Therapeutics Press Release
BOULDER, Colo., Dec. 24, 2025 -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), today announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical trial of EDG-7500, a novel oral,...
Edgewise Therapeutics Press Release
BOULDER, Colo., Dec. 24, 2025 -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), today announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical trial of EDG-7500, a novel oral,...
Edgewise Therapeutics Press...